Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Meta-Analysis: Probiotics Improve Motor, Nonmotor Symptoms in Parkinson Disease
04/24/2023
Jolynn Tumolo
New findings suggest oral probiotics improved motor symptoms as well as gastrointestinal, anxiety, and depressive symptoms in patients with Parkinson disease. 
New findings suggest oral probiotics improved motor symptoms as well as gastrointestinal, anxiety, and depressive symptoms in patients with Parkinson disease. 
New findings suggest oral...
04/24/2023
Annals of Long-Term Care
News
Fewer Black Patients Prescribed Novel Agents for CLL in the VA System
04/24/2023
Jolynn Tumolo
“Further studies should explore other socioeconomic and cultural factors that may drive these racial disparities, as well as the safety and effectiveness of treatments by race, to better understand how racial disparities might impact patient...
“Further studies should explore other socioeconomic and cultural factors that may drive these racial disparities, as well as the safety and effectiveness of treatments by race, to better understand how racial disparities might impact patient...
“Further studies should explore...
04/24/2023
First Report Managed Care
News
Treatment Preferences, Drivers Vary Widely Among Patients With Relapsing MS
04/24/2023
Jolynn Tumolo
When it comes to choosing treatments for patients with relapsing multiple sclerosis, there can be high variability in the importance patients place on different treatment factors, according to researchers.
When it comes to choosing treatments for patients with relapsing multiple sclerosis, there can be high variability in the importance patients place on different treatment factors, according to researchers.
When it comes to choosing...
04/24/2023
First Report Managed Care
News
Obesity, Metabolic Comorbidity Rates Up in Patients With Inflammatory Bowel Disease
04/21/2023
Jolynn Tumolo
Despite the prevalence of obesity and metabolic conditions increasing in patients with inflammatory bowel disease over the past decade, the prescription rate for anti-obesity medications has only slightly increased, researchers said.
Despite the prevalence of obesity and metabolic conditions increasing in patients with inflammatory bowel disease over the past decade, the prescription rate for anti-obesity medications has only slightly increased, researchers said.
Despite the prevalence of...
04/21/2023
First Report Managed Care
News
New Respiratory Syncytial Virus Prevention Options on the Horizon for Older Adults
04/21/2023
Jolynn Tumolo
“It is likely that multiple immunization strategies with complementary value, unique advantages, and use-case scenarios will shape the RSV prevention landscape," researchers said.
“It is likely that multiple immunization strategies with complementary value, unique advantages, and use-case scenarios will shape the RSV prevention landscape," researchers said.
“It is likely that multiple...
04/21/2023
Pharmacy Learning Network
News
Monoclonal Antibody Improves Type 2 Inflammation Biomarkers in Children With Asthma
04/21/2023
Jolynn Tumolo
Findings from a phase 3 study suggest two dose regimens of a monoclonal antibody were similarly efficacious for reducing type 2 inflammatory biomarkers in pediatric patients with asthma.
Findings from a phase 3 study suggest two dose regimens of a monoclonal antibody were similarly efficacious for reducing type 2 inflammatory biomarkers in pediatric patients with asthma.
Findings from a phase 3 study...
04/21/2023
First Report Managed Care
News
Continued Golimumab Superior to Withdrawal in Patients With Inactive NrAxSpa
04/21/2023
Jolynn Tumolo
Continued golimumab treatment was superior to withdrawal in preventing disease flares and achieving clinical responses in adults with inactive nonradiographic axial spondyloarthritis.
Continued golimumab treatment was superior to withdrawal in preventing disease flares and achieving clinical responses in adults with inactive nonradiographic axial spondyloarthritis.
Continued golimumab treatment...
04/21/2023
First Report Managed Care
News
JAK Inhibitor Improves Symptoms in Patients With Psoriatic Arthritis and Axial Involvement
04/21/2023
Jolynn Tumolo
In two phase 3 studies comparing upadacitinib to placebo and adalimumab, upadacitinib improved symptoms in patients with psoriatic arthritis and axial involvement.
In two phase 3 studies comparing upadacitinib to placebo and adalimumab, upadacitinib improved symptoms in patients with psoriatic arthritis and axial involvement.
In two phase 3 studies comparing...
04/21/2023
First Report Managed Care
News
RSV Vaccine Candidate Demonstrates Safety but no Increase in RSV-Neutralizing Antibody Titers
04/20/2023
Jolynn Tumolo
Researchers said outcomes will likely improve with future vaccine modifications and alterations to the study population.
Researchers said outcomes will likely improve with future vaccine modifications and alterations to the study population.
Researchers said outcomes will...
04/20/2023
First Report Managed Care
News
Digital Therapeutic for Insomnia Linked With Reduced Rates of Cardiovascular Events
04/19/2023
Jolynn Tumolo
Researchers examined the association between a prescription digital therapeutic designed to deliver cognitive behavioral therapy to patients with insomnia and the incidence of acute cardiovascular events requiring hospitalization.
Researchers examined the association between a prescription digital therapeutic designed to deliver cognitive behavioral therapy to patients with insomnia and the incidence of acute cardiovascular events requiring hospitalization.
Researchers examined the...
04/19/2023
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use